Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter to Mirati Therapeutics for claims made by the ...

This year's International Symposium on Liver Diseases (IISLD) 2024, held in the San Diego Convention Center, includes two key ...

As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the ...

Owners of a wholesale drug distributor were recently indicted in the Southern District of Florida for alleged engagement in a ...

In September of 2024, the U.S. Department of Health and Human Services (HHS) published its stamp of approval for telehealth accreditation programs. With federal backing, this may be an inflection ...

Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter to AbbVie, Inc., regarding a television ad starring Serena Williams for its migraine medicine Ubrelvy. According to the ...

In a recent global compliance presentation at the Informaconnect, Aggregate Spend and HCP Engagement, Elon Shelf, Senior ...

The United States Department of Justice (DOJ) and National Interventional Radiology Partners (NIRP) recently announced an $8.8 million settlement that resolves allegations that the company violated th ...

On June 28, 2024, the Supreme Court rejected the doctrine of Chevron deference in the closely watched case of Loper Bright Enterprises v. Raimondo. In a 6-3 decision, the Court held that Chevron’s rul ...

Sign up here to get the latest news and updates delivered directly to your inbox.